Serum Bicarbonate Changes Among Patients on Thrice Weekly Maintenance Hemodialysis (HD): A Single-Center Study
Serum Bicarbonate Changes Among Patients on Thrice-Weekly MHD
DOI:
https://doi.org/10.54393/pjhs.v6i3.2865Keywords:
Bicarbonate Changes, End Stage Renal Disease, Hemodialysis, Intra-Dialytic ChangesAbstract
Metabolic acidosis in hemodialysis significantly affects morbidity and mortality. Understanding bicarbonate fluctuations is key to optimizing supplementation and dialysis protocols. Objectives: To determine the inter-dialytic and intra-dialytic changes in serum bicarbonate level among patients undergoing maintenance hemodialysis. Methods: This quasi-experimental study was conducted at the Nephrology Department, Fatima Jinnah Medical University (FJMU)/Sir Ganga Ram Hospital, Lahore, after taking synopsis approval from the CPSP from August 2024 to January 2025. After taking consent, 60 patients on maintenance haemodialysis thrice weekly who met the selection criteria were enrolled. Inter-dialytic and intra-dialytic changes in serum bicarbonate levels were determined. Data were analyzed using SPSS version 26.0. Numerical values were presented as mean ± SD, and continuous variables were analysed using frequency and percentages. Inter-dialytic and intra-dialytic changes in bicarbonate levels were compared using a paired t-test; p≤0.05 was taken as significant. Results: Pre-hemodialysis mean bicarbonate level was 18.65 ± 1.11 mEq/L, increased to 22.18 ± 0.85 mEq/L post-hemodialysis, and by the next hemodialysis session, the mean pre-HD bicarbonate level reduced to 18.78 ± 1.02 mEq/L. Intra-dialytic change showed a mean increase of 3.53 ± 1.19 mEq/L, p-value<0.001 and inter-dialytic change demonstrated a decrease of 3.40 ± 1.18 mEq/L, p-value<0.001. Conclusions: It was concluded that hemodialysis temporarily raises bicarbonate levels, but they drop before the next session, highlighting the need for optimized supplementation or dialysis adjustments to maintain stability.
References
Kovesdy CP. Epidemiology of Chronic Kidney Disease: An Update 2022. Kidney International Supplements. 2022 Apr; 12(1): 7-11. doi: 10.1016/j.kisu.2021.11.003. DOI: https://doi.org/10.1016/j.kisu.2021.11.003
Ke C, Liang J, Liu M, Liu S, Wang C. Burden of Chronic Kidney Disease and Its Risk-Attributable Burden in 137 Low-And Middle-Income Countries, 1990–2019: Results from the Global Burden of Disease Study 2019. BioMed Central Nephrology. 2022 Dec; 23: 1-2. doi: 10.1186/s12882-021-02597-3. DOI: https://doi.org/10.1186/s12882-021-02597-3
Imtiaz S and Alam A. Epidemiology and demography of Chronic Kidney Disease in Pakistan-A review of Pakistani literature. Pakistan Journal of Kidney Diseases. 2023 Mar; 7(1): 2-7. doi: 10.53778/pjkd71209. DOI: https://doi.org/10.53778/pjkd71209
Kim HJ. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment. Electrolytes and Blood Pressure. 2021 Dec; 19(2): 29. doi: 10.5049/EBP.2021.19.2.29. DOI: https://doi.org/10.5049/EBP.2021.19.2.29
Mudunuru SA, Navarrete JE, O'Neill WC. Metabolic Alkalosis in Hemodialysis Patients: PO0893. Journal of the American Society of Nephrology. 2021 Oct; 32(10S): 305. doi: 10.1681/ASN.20213210S1305c. DOI: https://doi.org/10.1681/ASN.20213210S1305c
Ali M, Ejaz A, Iram H, Solangi SA, Junejo AM, Solangi SA. Frequency of Intradialytic Complications in Patients of End-Stage Renal Disease On Maintenance Hemodialysis. Cureus. 2021 Jan; 13(1). doi: 10.7759/cureus.12641. DOI: https://doi.org/10.7759/cureus.12641
Tantisattamo E, Murray V, Obi Y, Park C, Catabay CJ, Lee Y et al. Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD. American Journal of Nephrology. 2021 Jun; 52(4): 304-17. doi: 10.1159/000513855. DOI: https://doi.org/10.1159/000513855
Abramowitz MK. Bicarbonate Balance and Prescription in ESRD. Journal of the American Society of Nephrology. 2017 Mar; 28(3): 726-34. doi: 10.1681/ASN.2016070780. DOI: https://doi.org/10.1681/ASN.2016070780
Correa S, Scovner KM, Tumlin JA, Roy-Chaudhury P, Koplan BA, Costea AI et al. Electrolyte Changes in Contemporary Hemodialysis: A Secondary Analysis of the Monitoring in Dialysis Study. Kidney360. 2021 Apr; 2(4): 695-707. doi: 10.34067/KID.0007452020. DOI: https://doi.org/10.34067/KID.0007452020
Valério Alves R, Gonçalves H, Lopes K, Sofia F, Vila Lobos A. Changing the Paradigm of Bicarbonate (HCO 3−) Hemodialysis Prescription in Portugal: A 24-Month Prospective Study. Renal Replacement Therapy. 2020 Dec; 6: 1-5. doi: 10.1186/s41100-020-00302-y. DOI: https://doi.org/10.1186/s41100-020-00302-y
Abramowitz MK. Defining Acid-Base Status in Hemodialysis: Is Bicarbonate Enough? Kidney Medicine. 2020 Feb; 2(1): 1. doi: 10.1016/j.xkme.2020.01.003. DOI: https://doi.org/10.1016/j.xkme.2020.01.003
Stavroulopoulos A, Aresti V, Papadopoulos C, Nennes P, Metaxaki P, Galinas A. Bicarbonate Levels in Hemodialysis Patients Switching from Lanthanum Carbonate to Sucroferric Oxyhydroxide. World Journal of Nephrology. 2018 Oct; 7(6): 123. doi: 10.5527/wjn.v7.i6.123. DOI: https://doi.org/10.5527/wjn.v7.i6.123
Hussain F, Ashraf S, Arshad M, ur Rehman MM, Khan FS, Ahmad MA et al. Knowledge, Adherence, and Perception of Patients On Maintenance Hemodialysis to Treatment Regimens at A Tertiary Care Hospital in Pakistan. Cureus. 2023 Dec; 15(12). doi: 10.7759/cureus.51341. DOI: https://doi.org/10.7759/cureus.51341
Mujtaba F, Ahmad A, Dhrolia M, Qureshi R, Nasir K. Causes of Emergency Department Visits Among End-Stage Kidney Disease Patients on Maintenance Hemodialysis in Pakistan: A Single-Center Study. Cureus. 2022 Dec; 14(12). doi: 10.7759/cureus.33004. DOI: https://doi.org/10.7759/cureus.33004
Ejaz A, Junejo AM, Ali M, Ashfaq A, Hafeez AR, Khan SA. Outcomes of Dialysis Among Patients with End-Stage Renal Disease (ESRD). Cureus. 2021 Aug; 13(8). doi: 10.7759/cureus.17006. DOI: https://doi.org/10.7759/cureus.17006
Baig MA, Ansari TA, Mugheri AH, Jamali AH, Mushtaq F, Ali S. Determine the Frequency of Hepatitis B and C in Patients Undergoing Hemodialysis. Pakistan Journal of Medical and Health Sciences. 2022 Mar; 16(02): 130-. doi: 10.53350/pjmhs22162130. DOI: https://doi.org/10.53350/pjmhs22162130
Abd El Wahab KG, El Shennawy HA, Saeed SA, El Deeb M, Soliman AY, Mansour AM. The Effect of Oral Sodium Bicarbonate On the Improvement of Intradialytic Acidosis and Hyperkalemia in Prevalent Hemodialysis Patients. Journal of the Egyptian Society of Nephrology and Transplantation. 2024 Jul; 24(3): 154-8. doi: 10.4103/jesnt.jesnt_25_23. DOI: https://doi.org/10.4103/jesnt.jesnt_25_23
Kourtellidou SI, Ashby DR, Johansson LR. Oral Sodium Bicarbonate in People On Hemodialysis: A Randomized Controlled Trial. BioMed Central Nephrology. 2021 Dec; 22: 1-1. doi: 10.1186/s12882-021-02549-x. DOI: https://doi.org/10.1186/s12882-021-02549-x
Soliman AY, Hamid El Shennawy HA, Wahab Saeed SA, Deeb ME, Mansour AM, Abd El Wahab KG. The Effect of Oral Sodium Bicarbonate on the Improvement of Inter-Dialytic Acidosis and Hyperkalemia. QJM: An International Journal of Medicine. 2024 Oct; 117(Supplement_2): hcae175-355. doi: 10.1093/qjmed/hcae175.355. DOI: https://doi.org/10.1093/qjmed/hcae175.355
Panesar M, Shah N, Vaqar S, Ivaturi K, Gudleski G, Muscarella M et al. Changes in Serum Bicarbonate Levels Caused By Acetate‐Containing Bicarbonate‐Buffered Hemodialysis Solution: An Observational Prospective Cohort Study. Therapeutic Apheresis and Dialysis. 2017 Apr; 21(2): 157-65. doi: 10.1111/1744-9987.12510. DOI: https://doi.org/10.1111/1744-9987.12510
Bozikas A, Kiriakoutzik I, Petrou I, Touroutzis T, Kitoukidi E, Pisanidou P et al. Aiming for the Optimal Bicarbonate Prescription for Maintenance Hemodialysis Therapy in End‐Stage Renal Disease. Hemodialysis International. 2019 Apr; 23(2): 173-80. doi: 10.1111/hdi.12710. DOI: https://doi.org/10.1111/hdi.12710
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Health Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments